Regulation of autophagy protects against liver injury in liver surgery-induced ischaemia/reperfusion.
Chenxia HuLingfei ZhaoFen ZhangLan-Juan LiPublished in: Journal of cellular and molecular medicine (2021)
Transient ischaemia and reperfusion in liver tissue induce hepatic ischaemia/reperfusion (I/R) tissue injury and a profound inflammatory response in vivo. Hepatic I/R can be classified into warm I/R and cold I/R and is characterized by three main types of cell death, apoptosis, necrosis and autophagy, in rodents or patients following I/R. Warm I/R is observed in patients or animal models undergoing liver resection, haemorrhagic shock, trauma, cardiac arrest or hepatic sinusoidal obstruction syndrome when vascular occlusion inhibits normal blood perfusion in liver tissue. Cold I/R is a condition that affects only patients who have undergone liver transplantation (LT) and is caused by donated liver graft preservation in a hypothermic environment prior to entering a warm reperfusion phase. Under stress conditions, autophagy plays a critical role in promoting cell survival and maintaining liver homeostasis by generating new adenosine triphosphate (ATP) and organelle components after the degradation of macromolecules and organelles in liver tissue. This role of autophagy may contribute to the protection of hepatic I/R-induced liver injury; however, a considerable amount of evidence has shown that autophagy inhibition also protects against hepatic I/R injury by inhibiting autophagic cell death under specific circumstances. In this review, we comprehensively discuss current strategies and underlying mechanisms of autophagy regulation that alleviates I/R injury after liver resection and LT. Directed autophagy regulation can maintain liver homeostasis and improve liver function in individuals undergoing warm or cold I/R. In this way, autophagy regulation can contribute to improving the prognosis of patients undergoing liver resection or LT.
Keyphrases
- cell death
- endoplasmic reticulum stress
- cell cycle arrest
- signaling pathway
- end stage renal disease
- oxidative stress
- inflammatory response
- newly diagnosed
- cardiac arrest
- patients undergoing
- cerebral ischemia
- liver injury
- ejection fraction
- chronic kidney disease
- acute myocardial infarction
- prognostic factors
- drug induced
- peritoneal dialysis
- magnetic resonance imaging
- minimally invasive
- cell proliferation
- autism spectrum disorder
- lps induced
- heart failure
- atrial fibrillation
- brain injury
- stress induced
- acute ischemic stroke
- patient reported outcomes
- percutaneous coronary intervention
- high glucose